We are live on
!
Find out more
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.8B
AUM Growth
-$67.5M
(-0.42%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
30.69%
Holding
1,298
New
335
Increased
347
Reduced
276
Closed
290
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$471M |
| 2 |
Sandisk
SNDK
|
+$313M |
| 3 |
Goldman Sachs
GS
|
+$179M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$144M |
| 5 |
Eli Lilly
LLY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$174M |
| 3 |
NVIDIA
NVDA
|
+$137M |
| 4 |
Home Depot
HD
|
+$131M |
| 5 |
Netflix
NFLX
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.11% |
| 2 | Technology | 25% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 4.76% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
701
Definium Therapeutics
DFTX
$4.6B
| $378K | ﹤0.01% |
20,000
| – | – |
2025 Q4
1 quarter
|
|
702
Simplify Managed Futures Strategy ETF
CTA
$1.35B
| $378K | ﹤0.01% |
+12,500
| New | +$363K |
2026 Q1
0 quarters
|
|
703
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.4B
| $377K | ﹤0.01% |
+12,500
| New | +$375K |
2026 Q1
0 quarters
|
|
704
Axon Enterprise
AXON
$33.9B
| $375K | ﹤0.01% |
884
+67
| +8% | +$34.8K |
2025 Q3
2 quarters
|
|
705
ProShares Ultra Bloomberg Natural Gas
BOIL
$331M
| $375K | ﹤0.01% |
11,638
+5,679
| +95% | +$227K |
2025 Q3
2 quarters
|
|
706
Blue Owl Capital
OWL
$6.13B
| $375K | ﹤0.01% |
+41,091
| New | +$497K |
2026 Q1
0 quarters
|
|
707
CALL
Intel
INTC
$504B
| $375K | ﹤0.01% |
8,500
-299,500
| -97% | -$13.7M |
2025 Q2
3 quarters
|
|
708
YPF Sociedad Anonima ADS
YPF
$20B
| $373K | ﹤0.01% |
8,060
-1,642
| -17% | -$62.1K |
2025 Q3
2 quarters
|
|
709
Ballard Power Systems
BLDP
$586M
| $370K | ﹤0.01% |
152,761
| – | – |
2024 Q2
7 quarters
|
|
710
Larimar Therapeutics
LRMR
$207M
| $369K | ﹤0.01% |
82,000
-230,000
| -74% | -$919K |
2025 Q3
2 quarters
|
|
711
Vista Energy
VIST
$7.74B
| $369K | ﹤0.01% |
4,886
-24,700
| -83% | -$1.44M |
2025 Q4
1 quarter
|
|
712
DELISTED
Avanos Medical
AVNS
| $361K | ﹤0.01% |
25,800
| – | – |
2025 Q3
2 quarters
|
|
713
BridgeBio Pharma
BBIO
$13.1B
| $361K | ﹤0.01% |
+4,860
| New | +$352K |
2026 Q1
0 quarters
|
|
714
Lennar Class A
LEN
$18.5B
| $360K | ﹤0.01% |
4,144
+1,573
| +61% | +$170K |
2025 Q4
1 quarter
|
|
715
Noble Corp
NE
$6.85B
| $359K | ﹤0.01% |
7,310
| – | – |
2025 Q3
2 quarters
|
|
716
Public Storage
PSA
$55.2B
| $358K | ﹤0.01% |
1,320
+215
| +19% | +$61.6K |
2025 Q4
1 quarter
|
|
717
Bank of America Series L
BAC.PRL
$3.63B
| $357K | ﹤0.01% |
+300
| New | +$371K |
2026 Q1
0 quarters
|
|
718
AdaptHealth
AHCO
$852M
| $357K | ﹤0.01% |
+30,028
| New | +$307K |
2026 Q1
0 quarters
|
|
719
Sprott Copper Miners ETF
COPP
$269M
| $357K | ﹤0.01% |
+10,000
| New | +$389K |
2026 Q1
0 quarters
|
|
720
Ford
F
$49.1B
| $354K | ﹤0.01% |
30,656
+11,634
| +61% | +$153K |
2025 Q4
1 quarter
|
|
721
Estee Lauder
EL
$38.8B
| $352K | ﹤0.01% |
+4,901
| New | +$501K |
2026 Q1
0 quarters
|
|
722
iShares MSCI India ETF
INDA
$5.94B
| $350K | ﹤0.01% |
7,466
+2,236
| +43% | +$115K |
2023 Q3
10 quarters
|
|
723
RH
RH
$2.23B
| $350K | ﹤0.01% |
2,501
+283
| +13% | +$51.6K |
2025 Q2
3 quarters
|
|
724
Morgan Stanley Direct Lending Fund
MSDL
$1.12B
| $349K | ﹤0.01% |
25,000
-46,050
| -65% | -$712K |
2025 Q3
2 quarters
|
|
725
Invesco Preferred ETF
PGX
$3.64B
| $348K | ﹤0.01% |
32,000
-188,021
| -85% | -$2.13M |
2025 Q4
1 quarter
|
|
Similar funds
Marex Group's Q1 2026 Portfolio in Review
As of Q1 2026, Marex Group held 1,298 positions worth $15.8B, down 0.42% from $15.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marex Group deployed $1.48B of net new capital in Q1 2026, opening 335 new positions and adding to 347 existing holdings. Its largest new stake was Lumentum: 857,171 shares worth $602M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $304M trimmed.
- Marex Group's largest Q1 2026 buy was Lumentum: 857,171 shares worth $602M.
- Marex Group added most to Goldman Sachs in Q1 2026, an estimated $179M increase.
- Marex Group's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $304M.
- Marex Group fully exited Dycom Industries in Q1 2026, selling an estimated $13.3M.
- Marex Group's ten largest holdings make up 31% of its $15.8B portfolio in Q1 2026.
- Marex Group opened 335 new positions and closed 290 in Q1 2026.
- Marex Group's portfolio value fell 0.42% quarter-over-quarter to $15.8B.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.